These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial. Shaker H, Jahanian F, Fathi M, Zare M. Ther Adv Cardiovasc Dis; 2015 Feb; 9(1):4-9. PubMed ID: 25297337 [Abstract] [Full Text] [Related]
17. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ. Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397 [Abstract] [Full Text] [Related]
18. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Madsen CD, Pointer JE, Lynch TG. Ann Emerg Med; 1995 May 25; 25(5):649-55. PubMed ID: 7741343 [Abstract] [Full Text] [Related]
20. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia. Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF. Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]